When was Milestone Pharmaceuticals Inc. stock made available for the first time to the public?

The IPO Date for Milestone Pharmaceuticals Inc. is 2019-05-09. On this 2019-05-09, Milestone Pharmaceuticals Inc. stock was made publicly available.

Where is the headquarters of Milestone Pharmaceuticals Inc. stock?

Headquarters of Milestone Pharmaceuticals Inc. is in CA at 1111 Dr. Frederik-Philips Boulevard, Montreal, QC H4M 2X6.

What industry does Milestone Pharmaceuticals Inc. belong to?

The Milestone Pharmaceuticals Inc. belongs to Biotechnology.

Milestone Pharmaceuticals Inc.

MIST•NASDAQ

Healthcare

Biotechnology

$1.56

$-1.00(-39.06%)

Milestone Pharmaceuticals Inc. (MIST) Company Profile & Overview

Explore Milestone Pharmaceuticals Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Milestone Pharmaceuticals Inc. (MIST) Company Profile & Overview

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil prophylactic and therapeutic uses in humans. The company was incorporated in 2003 and is headquartered in Montréal, Canada.

SectorHealthcare

IndustryBiotechnology

CEOJoseph G. Oliveto

Contact Information

https://www.milestonepharma.com

15143360444

1111 Dr. Frederik-Philips Boulevard, Montreal, QC, H4M 2X6

Company Facts

33 Employees

IPO DateMay 9, 2019

CountryCA

Actively Trading

Frequently Asked Questions

;